Development of a particle agglutination method with soluble virus receptor for identification of poliovirus

Minetaro Arita1, Souji Masujima, Takaji Wakita

  • 1Department of Virology II, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama-shi, Tokyo 208-0011, Japan. minetaro@nih.go.jp

Insights

A new particle agglutination (PA) method uses human poliovirus receptor (hPVR) to rapidly identify poliovirus (PV) in acute flaccid paralysis (AFP) cases. This simple test is useful but may miss minor PV strains in mixed infections.

Area of Science:

  • Virology
  • Immunology
  • Diagnostic Microbiology

Background:

  • Laboratory diagnosis is crucial for the Global Polio Eradication Initiative.
  • Accurate identification of poliovirus (PV) from acute flaccid paralysis (AFP) patient stool samples is essential.

Purpose of the Study:

  • To develop a simple and rapid particle agglutination (PA) method for poliovirus identification.
  • To utilize a soluble human PV receptor (hPVR) immunoadhesin (PVR-IgG2a) for enhanced specificity.

Main Methods:

  • Developed a one-step particle agglutination (PA) assay using gelatin particles sensitized with PVR-IgG2a.
  • Tested the method's efficacy with cultured poliovirus strains and clinical isolates from AFP cases.

Main Results:

  • The PA method achieved specific agglutination with PV-infected cell culture fluid within 2 hours.
  • Detection limits for Sabin strains were 1.5 x 10^6 (Type 1), 5.3 x 10^5 (Type 2), and 9.1 x 10^5 (Type 3) CCID50.
  • Wild-type PVs and clinical isolates were correctly identified, with limitations in detecting minor PV serotypes in mixed infections.

Conclusions:

  • The developed PA method offers a simple and rapid approach for poliovirus identification.
  • While effective for major PV strains, the method's sensitivity requires improvement for detecting minor PV populations in mixed samples.

Related Concept Videos